References
- Barker DJ. (1998). In utero programming of chronic disease. Clin Sci (Lond) 95:115–28
- Bassareo PP, Fanos V, Puddu M, et al. (2014). Advanced intrauterine growth restriction is associated with reduced excretion of asymmetric dimethylarginine. Early Hum Dev 90:173–6
- Battista MC, Oligny LL, St-Louis J, Brochu M. (2002). Intrauterine growth restriction in rats is associated with hypertension and renal dysfunction in adulthood. Am J Physiol Endocrinol Metab 283:E124–31
- Caplin B, Leiper J. (2012). Endogenous nitric oxide synthase inhibitors in the biology of disease: markers, mediators, and regulators? Arterioscler Thromb Vasc Biol 32:1343–53
- Edvardsson VO, Steinthorsdottir SD, Eliasdottir SB, et al. (2012). Birth weight and childhood blood pressure. Curr Hypertens Rep 14:596–602
- Filler G, Reimão SM, Kathiravelu A, et al. (2007). Pediatric nephrology patients are overweight: 20 years' experience in a single Canadian tertiary pediatric nephrology clinic. Int Urol Nephrol 39:1235–40
- Gluckman PD, Harding JE. (1997). The physiology and pathophysiology of intrauterine growth retardation. Horm Res 48:11–16
- Hughson MD, Douglas-Denton R, Bertram JF, Hoy WE. (2006). Hypertension, glomerular number, and birth weight in African Americans and white subjects in the southeastern United States. Kidney Int 69:671–8
- Jaźwińska-Kozuba A, Martens-Lobenhoffer J, Surdack A, et al. (2012). Associations between endogenous dimethylarginines and renal function in healthy children and adolescents. Int J Mol Sci 13:4–74
- Kielstein JT, Fliser D, Veldink H. (2009). Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 22:346–50
- Lüneburg N, Von Holten RA, Töpper RF, et al. (2012). Symmetric dimethylarginine is a marker of detrimental outcome in the acute phase after ischaemic stroke: role of renal function. Clin Sci (Lond) 122:105–11
- Mañalich R, Reyes L, Herrera M, et al. (2000). Relationship between weight at birth and the number and size of renal glomeruli in humans: a histomorphometric study. Kidney Int 58:770–3
- Nijveldt RJ, Teerlink T, Van Guldener C, et al. (2003). Handling of asymmetrical dimethylarginine and symmetrical dimethylarginine by the rat kidney under basal conditions and during endotoxaemia. Nephrol Dial Transplant 18:2542–50
- Schepers E, Barreto DV, Liabeuf S, et al. (2011). Symmetric dimethylarginine as a proinflammatory agent in chronic kidney disease. Clin J Am Soc Nephrol 6:2374–83
- Schwartz GJ, Muñoz A, Schneider MF, et al. (2009). New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–37
- Schwedhelm E, Böger RH. (2011). The role of asymmetric and symmetric dimethylarginines in renal disease. Nat Rev Nephrol 7:275–85
- Stapleton FB, Jones DP, Green RS. (1987). Acute renal failure in neonates: incidence, etiology and outcome. Pediatr Nephrol 1:314–20
- Surdacki A. (2008). L-arginine analogs–inactive markers or active agents in atherogenesis? Cardiovasc Hematol Agents Med Chem 6:302–11
- Tonelli M, Wiebe N, Culleton B, et al. (2006). Chronic kidney disease and mortality risk: a systematic review. J Am Soc Nephrol 17:2034–47
- Tufro A, Norwood VF, Carey RM, Gomez RA. (1999). Vascular endothelial growth factor induces nephrogenesis and vasculogenesis. J Am Soc Nephrol 10:2125–34
- Vida G, Sulyok E, Lakatos O, et al. (2009). Plasma levels of asymmetric dimethylarginine in premature neonates: its possible involvement in developmental programming of chronic diseases. Acta Paediatr 98:437–41